Neuropsychiatric lupus: clinical and imaging aspects.

Neuropsychiatric lupus (NPSLE) manifestations are common in adults and children and are associated with an increase in both morbidity and mortality. Cognitive dysfunction, when standardly assessed using sensitive neurocognitive instruments, is the most common NPSLE manifestation. The pathogenic etiologies of NPSLE manifestations are likely to be multifactorial and may involve autoantibody production, microangiopathy, intrathecal production of proinflammatory cytokines and athersclerosis. It is becoming more clear that the integrity of the blood-brain-barrier is very important in SLE-related neuropathology. Brain imaging is an important tool that allows us to evaluate the living brain. Thus far, anatomic brain imaging has revealed abnormalities such as subcortical white matter lesions and cerebral atrophy, but these findings are non-specific. Methods that evaluate metabolic processes and other functional imaging techniques have more promise as surrogates for central nervous system damage. This article reviews the current literature on clinical and imaging aspects of NPSLE.

[1]  B. Chiang,et al.  Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study , 2006, Lupus.

[2]  G. Gronseth,et al.  Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions , 2002, Neurology.

[3]  I. Bruce,et al.  Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. , 2007, Arthritis and rheumatism.

[4]  S. Ikeda,et al.  Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus , 2005, Clinical Rheumatology.

[5]  B. Volpe,et al.  Human lupus autoantibodies against NMDA receptors mediate cognitive impairment , 2006, Proceedings of the National Academy of Sciences.

[6]  J. Peltola,et al.  The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus , 2001, Neurology.

[7]  J. Hanly,et al.  Brain pathology in systemic lupus erythematosus. , 1992, The Journal of rheumatology.

[8]  S. West,et al.  Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. , 2006, Arthritis and rheumatism.

[9]  J. Gómez-Reino,et al.  Magnetic resonance imaging of the brain in systemic lupus erythematosus. , 1995, British journal of rheumatology.

[10]  S. Pierangeli,et al.  Antiphospholipid Antibodies in an in vivo Thrombosis Model in Mice , 1994, Lupus.

[11]  J. Ioannidis,et al.  Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. , 2000, The American journal of medicine.

[12]  E. Nitzsche,et al.  Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: A controlled positron emission tomography study , 1997, European Journal of Nuclear Medicine.

[13]  R. Jonsson,et al.  Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors , 2005, European journal of neurology.

[14]  H. Zinger,et al.  Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.

[15]  M. Ward Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. , 2004, Journal of women's health.

[16]  L. Csiba,et al.  MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension , 2003, Journal of Neurology.

[17]  B. Diamond,et al.  A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus , 2001, Nature Medicine.

[18]  H. Deicher,et al.  Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus , 1997, Journal of Neurology.

[19]  Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings. , 1994, Radiology.

[20]  F. Fazekas,et al.  Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings. , 1995, Stroke.

[21]  G. Hughes,et al.  Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. , 1995, The American journal of medicine.

[22]  C. Millikan,et al.  Central nervous system disease in patients with systemic lupus erythematosus , 1992, Neurology.

[23]  P. Williams,et al.  Predictors of cognitive dysfunction in patients with systemic lupus erythematosus , 2005, Neurology.

[24]  N. Abbott,et al.  The blood-brain barrier in systemic lupus erythematosus , 2003, Lupus.

[25]  C. Sandborg,et al.  Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. , 2006, The Journal of rheumatology.

[26]  W. Brooks,et al.  The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. , 2002, The Journal of rheumatology.

[27]  J. Fried,et al.  Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage. , 2004, Frontiers in bioscience : a journal and virtual library.

[28]  S. Abramson,et al.  Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. , 1996, Arthritis and rheumatism.

[29]  M. Liang,et al.  Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. , 2000, The Journal of rheumatology.

[30]  J. Satia,et al.  Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden , 2006, Lupus.

[31]  D. Gladman,et al.  Mortality related to cerebrovascular disease in systemic lupus erythematosus , 2006, Lupus.

[32]  J. Mikdashi,et al.  Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. , 2004, Rheumatology.